Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Xilio Therapeutics, Inc. (XLO)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 26,671,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Xilio Therapeutics is a biotechnology company focused on harnessing the immune system to achieve clinical responses to improve the lives of patients with cancer. Co. is developing a number of tumor-selective, agents through various stages of development. Co.'s product candidates are XTX101, an anti-cytotoxic T-lymphocyte-associated protein 4 monoclonal antibody and XTX202, an interleukin 2 therapy. Co. is also developing its tumor-selective IL-12 product candidate, XTX301 and is focusing on preclinical studies for its tumor-selective IL-15 product candidate, XTX401. Co. has worldwide development and commercialization rights to all of its product candidates.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 485,250 485,250 485,250 485,250
Total Buy Value $368,790 $368,790 $368,790 $368,790
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 1,000 5,235 5,235 5,235
Total Sell Value $640 $4,240 $4,240 $4,240
Total People Sold 1 1 1 1
Total Sell Transactions 2 6 6 6
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 41
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gilead Sciences Inc 10% Owner   –       –       •   2024-04-02 4 B $0.76 $368,790 D/D 485,250 7,345,473 2.45     -
   Gilead Sciences Inc 10% Owner   –       –       •   2024-03-27 3 IO $0.00 $0 D/D 0 6,860,223     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-02-08 4 S $0.64 $171 I/I (267) 734,546     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-02-08 4 S $0.64 $469 D/D (733) 2,019,563     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-01-12 4 S $0.83 $465 I/I (560) 734,813     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-01-12 4 S $0.83 $1,278 D/D (1,540) 2,020,296     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-01-11 4 S $0.87 $495 I/I (569) 735,373     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2024-01-11 4 S $0.87 $1,362 D/D (1,566) 2,021,836     -
   English Edward C Principal Accounting Officer   •       –      –    2022-11-09 3 IO $0.00 $0 D/D 0 6,002     -
   Bcip Life Sciences Associates, Lp 10% Owner   –       –       •   2021-12-10 4 B $9.56 $241,202 I/I 25,000 2,805,413 1.5     -
   Bcip Life Sciences Associates, Lp 10% Owner   –       –       •   2021-12-09 4 B $9.84 $39,485 I/I 4,011 2,780,413 1.5     -
   Bcip Life Sciences Associates, Lp 10% Owner   –       –       •   2021-12-08 4 B $9.62 $129,474 I/I 13,458 2,776,402 1.5     -
   Bcip Life Sciences Associates, Lp 10% Owner   –       –       •   2021-10-26 3 IO $0.00 $0 I/I 0 2,762,944     -
   Sv7 (imf) Gp Llp 10% Owner   –       –       •   2021-10-26 4/A B $16.00 $5,000,000 I/I 312,500 1,613,632 1.5     -
   Sv7 (imf) Gp Llp 10% Owner   –       –       •   2021-10-26 4/A B $16.00 $5,000,000 D/D 312,500 1,613,632 2.45     -
   Fmr Corp See Remark 1   –       –      –    2021-10-26 4 A $0.00 $0 I/I 1,881,355 4,465     -
   Fil Ltd See Remark 1   –       –      –    2021-10-26 4 A $0.00 $0 I/I 218,705 218,705     -
   Sv7 (imf) Gp Llp 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 I/I 1,301,132 1,301,132     -
   Sv7 (imf) Gp Llp 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 D/D 1,301,132 1,301,132     -
   Deerfield Mgmt V, L.p. Possible Member of 10% Group   –       –       •   2021-10-26 4 B $16.00 $12,400,000 I/I 775,000 1,143,972 1.5     -
   Deerfield Mgmt V, L.p. Possible Member of 10% Group   –       –       •   2021-10-26 4 A $0.00 $0 I/I 1,512,944 756,472     -
   Takeda Ventures, Inc. 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 I/I 1,475,121 1,475,121     -
   Rivervest Venture Fund Iv, L.p. 10% Owner   –       –       •   2021-10-26 4 B $16.00 $4,000,000 I/I 250,000 1,441,444 1.5     -
   Rivervest Venture Fund Iv, L.p. 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 I/I 1,191,444 1,191,444     -
   Merck Kgaa 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 I/I 680,825 680,825     -
  41 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us